Table 2.
Univariate and multivariate logistic regression analyses of predictors for greater percent increases in LS-BMD at 24 months
| Univariate | Multivariate | |||||
| Odds ratio | 95% confidence interval | Odds ratio | 95% confidence interval | p Value | ||
| Age (years) | 1.074 | 1.001–1.151 | 1.094 | 0.998–1.198 | 0.0544 | |
| MTX use | 0.270 | 0.080–0.914 | 0.426 | 0.102–1.773 | 0.2408 | |
| Prior treatment of BPs | 0.4052 | 0.144–1.143 | 1.027 | 0.249–4.230 | 0.9705 | |
| Percent change in P1NP at 6 months (%) | 0.9859 | 0.974–0.998 | 0.983 | 0.968–0.999 | 0.0420 | |
BMD, bone mineral density; BP, bisphosphonate; LS, lumbar spine; MTX, methotrexate; P1NP, N-terminal propeptide of type 1 collagen.